Unknown

Dataset Information

0

A functional assay for serum detection of antibodies against SARS-CoV-2 nucleoprotein


ABSTRACT: The humoral immune response to SARS-CoV-2 results in antibodies against spike (S) and nucleoprotein (N). However, whilst there are widely-available neutralization assays for S-antibodies, there is no assay for N-antibody activity. Here we present a simple in vitro method called EDNA (electroporated-antibody dependent neutralization assay) that provides a quantitative measure of N-antibody activity in unpurified serum from SARS-CoV-2 convalescents. We show that N-antibodies neutralize SARS-CoV-2 intracellularly and cell-autonomously but require the cytosolic Fc-receptor TRIM21. Using EDNA, we show that low N-antibody titres can be neutralizing, whilst some convalescents possess serum with high titres but weak activity. N-antibody and N-specific T cell activity correlates within individuals, suggesting N-antibodies may protect against SARS-CoV-2 by promoting antigen presentation. This work highlights the potential benefits of N-based vaccines and provides an in vitro assay to allow the antibodies they induce to be tested.

SUBMITTER: Dr. Anna Albecka 

PROVIDER: S-SCDT-EMBOJ-2021-108588 | biostudies-other |

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC8408615 | biostudies-literature
| S-EPMC7977152 | biostudies-literature
| S-EPMC9228376 | biostudies-literature
| S-EPMC7555114 | biostudies-literature
| EGAS00001004412 | EGA
| S-EPMC8664206 | biostudies-literature
| S-EPMC7928199 | biostudies-literature
| S-BSST379 | biostudies-other
| S-EPMC7316280 | biostudies-literature
| S-EPMC9241621 | biostudies-literature